Holen Sie sich die Stockscreener-App
4.85
3.00%
-0.15
Handel nachbörslich:
4.99
0.14
+2.89%
Finanzdaten der Corvus Pharmaceuticals Inc-Aktie (CRVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.65%
6.253
|
5.651 | 5.56 | 5.622 | 6.574 |
| Depreciation and Amortization |
70.13%
0.023
|
0.077 | 0.03 | 0.036 | 0.057 |
| Operating Income/Loss |
10.65%
-6.253
|
-5.651 | -5.56 | -5.622 | -6.574 |
| Income/Loss Before Equity Method Investments |
-5.937
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
10.76%
-5.937
|
-6.653 | -6.00 | -6.503 | -7.873 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
10.76%
-5.937
|
-6.653 | -6.00 | -6.503 | -7.873 |
|
Net Income/Loss
|
14.31%
-5.701
|
-6.653 | -6.00 | -6.503 | -7.873 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
14,261%
49.04
|
0.3415 | 48.97 | 47.50 | 46.56 |
| Diluted Average Shares |
14,261%
49.04
|
0.3415 | 48.97 | 47.50 | 46.56 |
| Basic Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.12 | -0.14 | -0.17 |
| Diluted Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.12 | -0.14 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):